GB0600916D0 - detecting and predicting pre-eclampsia - Google Patents

detecting and predicting pre-eclampsia

Info

Publication number
GB0600916D0
GB0600916D0 GBGB0600916.1A GB0600916A GB0600916D0 GB 0600916 D0 GB0600916 D0 GB 0600916D0 GB 0600916 A GB0600916 A GB 0600916A GB 0600916 D0 GB0600916 D0 GB 0600916D0
Authority
GB
United Kingdom
Prior art keywords
eclampsia
detecting
predicting
predicting pre
technology described
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0600916.1A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Revvity Health Sciences Inc
Original Assignee
PerkinElmer LAS Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PerkinElmer LAS Inc filed Critical PerkinElmer LAS Inc
Priority to GBGB0600916.1A priority Critical patent/GB0600916D0/en
Publication of GB0600916D0 publication Critical patent/GB0600916D0/en
Priority to US11/623,480 priority patent/US7638287B2/en
Priority to AU2007206756A priority patent/AU2007206756B2/en
Priority to HK08112797.2A priority patent/HK1119244B/en
Priority to DE602007013524T priority patent/DE602007013524D1/de
Priority to CA2602681A priority patent/CA2602681C/en
Priority to ES07700392T priority patent/ES2364314T3/es
Priority to JP2008549934A priority patent/JP2009524014A/ja
Priority to PCT/GB2007/000123 priority patent/WO2007083099A1/en
Priority to AT07700392T priority patent/ATE504002T1/de
Priority to EP07700392A priority patent/EP1974220B1/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/715—Assays involving receptors, cell surface antigens or cell surface determinants for cytokines; for lymphokines; for interferons
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Mold Materials And Core Materials (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Holo Graphy (AREA)
GBGB0600916.1A 2006-01-17 2006-01-17 detecting and predicting pre-eclampsia Ceased GB0600916D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GBGB0600916.1A GB0600916D0 (en) 2006-01-17 2006-01-17 detecting and predicting pre-eclampsia
US11/623,480 US7638287B2 (en) 2006-01-17 2007-01-16 Detecting and predicting pre-eclampsia
EP07700392A EP1974220B1 (en) 2006-01-17 2007-01-17 Detecting and predicting pre-eclampsia
DE602007013524T DE602007013524D1 (de) 2006-01-17 2007-01-17 Erkennung und vorhersage von frühgeburten
HK08112797.2A HK1119244B (en) 2006-01-17 2007-01-17 Detecting and predicting pre-eclampsia
AU2007206756A AU2007206756B2 (en) 2006-01-17 2007-01-17 Detecting and predicting pre-eclampsia
CA2602681A CA2602681C (en) 2006-01-17 2007-01-17 Detecting and predicting pre-eclampsia
ES07700392T ES2364314T3 (es) 2006-01-17 2007-01-17 Detección y predicción de preeclampsia.
JP2008549934A JP2009524014A (ja) 2006-01-17 2007-01-17 子癇前症の検出及び予測
PCT/GB2007/000123 WO2007083099A1 (en) 2006-01-17 2007-01-17 Detecting and predicting pre-eclampsia
AT07700392T ATE504002T1 (de) 2006-01-17 2007-01-17 Erkennung und vorhersage von frühgeburten

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0600916.1A GB0600916D0 (en) 2006-01-17 2006-01-17 detecting and predicting pre-eclampsia

Publications (1)

Publication Number Publication Date
GB0600916D0 true GB0600916D0 (en) 2006-02-22

Family

ID=35998177

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0600916.1A Ceased GB0600916D0 (en) 2006-01-17 2006-01-17 detecting and predicting pre-eclampsia

Country Status (10)

Country Link
US (1) US7638287B2 (enExample)
EP (1) EP1974220B1 (enExample)
JP (1) JP2009524014A (enExample)
AT (1) ATE504002T1 (enExample)
AU (1) AU2007206756B2 (enExample)
CA (1) CA2602681C (enExample)
DE (1) DE602007013524D1 (enExample)
ES (1) ES2364314T3 (enExample)
GB (1) GB0600916D0 (enExample)
WO (1) WO2007083099A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008098734A1 (en) 2007-02-12 2008-08-21 Stefan Hansson Diagnosis and treatment of preeclampsia
GB0715030D0 (en) * 2007-08-02 2007-09-12 Wilson Carol J Testing process
US8647832B2 (en) 2008-01-25 2014-02-11 Perkinelmer Health Sciences, Inc. Methods for determining the risk of prenatal complications
CN102224422A (zh) * 2008-11-20 2011-10-19 珀金埃尔默健康科学公司 使用pigf-2和pigf-3标志物确定先兆子痫风险的方法
WO2010091253A1 (en) 2009-02-06 2010-08-12 Women & Infants' Hospital Of Rhode Island Compositions, formulations and methods of treating preeclampsia-type disorders of pregnancy
AU2011231982B2 (en) * 2010-03-24 2014-02-20 Preelumina Diagnostics Ab HbF and A1M as early stage markers for preeclampsia
WO2013087887A2 (en) * 2011-12-15 2013-06-20 Pronota N.V. Biomarkers and parameters for hypertensive disorders of pregnancy
ES2718905T3 (es) * 2012-04-24 2019-07-05 Siemens Healthcare Diagnostics Inc Métodos de examen de preeclampsia
WO2014124396A1 (en) * 2013-02-08 2014-08-14 University Of Iowa Research Foundation Therapeutic strategies for the treatment of preeclampsia
US10119978B2 (en) * 2013-03-15 2018-11-06 Wallac Oy System and method for determining risk of diabetes based on biochemical marker analysis
EP3189336B1 (en) 2014-09-02 2018-11-07 Wallac OY Method for determining risk of pre-eclampsia
FR3037657B1 (fr) * 2015-06-22 2017-06-23 Univ Rouen Centre Hospitalier Methode de diagnostic des troubles causes par l'alcoolisation foetale
US20200395127A1 (en) * 2017-11-17 2020-12-17 University Of Washington Connected system for information-enhanced test results
EP4070113A4 (en) 2019-12-04 2023-12-20 Biora Therapeutics, Inc. ASSESSMENT OF PREECAMPSIA USING FREE AND DISSOCIATE PLACENTAL GROWTH FACTOR ASSAYS
GB2620035A (en) * 2021-02-10 2023-12-27 Mirvie Inc Methods and systems for conducting pregnancy-related clinical trials
FR3157091A1 (fr) * 2023-12-26 2025-06-27 Universite De Montpellier Prédiction du comportement biomécanique de la paroi artérielle à travers l’analyse temporelle du signal oscillométrique au cours de la mesure de pression

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5331298A (en) 1996-12-23 1998-07-17 Cambridge University Technical Services Limited Diagnosis and treatment of pathological pregnancies
GB0026823D0 (en) 2000-11-02 2000-12-20 King S College London Diagnosis of pre-eclampsia
US7435419B2 (en) * 2002-07-19 2008-10-14 Beth Israel Deaconess Medical Center Methods of diagnosing and treating pre-eclampsia or eclampsia
GB0308967D0 (en) * 2003-04-17 2003-05-28 Univ London Screen for pre-eclampsia
US7344892B2 (en) * 2003-09-23 2008-03-18 Beth Israel Deaconess Medical Center, Inc. Screening for gestational disorders
CA2485722A1 (en) * 2003-10-22 2005-04-22 Paul Lehmann Soluble transferrin receptor

Also Published As

Publication number Publication date
ES2364314T8 (es) 2011-09-22
CA2602681A1 (en) 2007-07-26
CA2602681C (en) 2017-03-14
AU2007206756A1 (en) 2007-07-26
US20070178530A1 (en) 2007-08-02
AU2007206756B2 (en) 2011-06-16
EP1974220A1 (en) 2008-10-01
JP2009524014A (ja) 2009-06-25
EP1974220B1 (en) 2011-03-30
WO2007083099A1 (en) 2007-07-26
US7638287B2 (en) 2009-12-29
DE602007013524D1 (de) 2011-05-12
ATE504002T1 (de) 2011-04-15
HK1119244A1 (en) 2009-02-27
ES2364314T3 (es) 2011-08-31

Similar Documents

Publication Publication Date Title
ES2364314T8 (es) Detección y predicción de preeclampsia.
WO2012021795A3 (en) Pancreatic cancer biomarkers and uses thereof
EP2114241A4 (en) METHOD AND SYSTEM FOR PROVIDING ANALYTE MONITORING
WO2010129934A3 (en) Methods and compositions for diagnosis of thyroid conditions
WO2009129505A3 (en) Compositions, methods, and kits using synthetic probes for determining the presence of a target nucleic acid
WO2007100506A3 (en) Mass tags for quantitative analyses
WO2008024473A3 (en) Mapping of genomic interactions
WO2010019414A3 (en) Detecting nucleic acid
WO2010065568A3 (en) METHODS AND ASSAYS FOR MEASURING p95 AND/OR p95 IN A SAMPLE AND ANTIBODIES SPECIFIC FOR p95
WO2010075360A3 (en) Methods for detection of sepsis
WO2009105212A3 (en) Detection of polyomavirus
WO2012037937A3 (de) Verfahren zum nachweis, differenzieren und quantifizieren von t-zellpopulationen mittels der reverse transkription quantitativen real-time pcr (rt-qpcr) technologie
EP2011868A4 (en) MODIFIED CREATININAMIDE HYDROLASE WITH IMPROVED SUBSTRATEFFINITY AND REAGENT COMPOSITION FOR THE DETERMINATION OF CREATININE
WO2010092164A3 (en) Bacterial dna as markers of cardiovascular and/or metabolic disease
TW200636075A (en) Detection of nucleic acid variation by cleavage-amplification method
WO2011142781A3 (en) Pore-limit electrophoresis (ple) microchannel assays
TW200745551A (en) Device and methods for detecting and quantifying one or more target agents
ATE500503T1 (de) Cd86- und cd80-rezeptorkonkurrenztests
DK2118666T3 (da) Fremgangsmåde til normalisering af koncentrationen af analytter i en urinprøve
WO2008034622A3 (en) A method of detecting and/or quantifying expression of a target protein candidate in a cell, and a method of identifying a target protein of a small molecule modulator
NZ601648A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2009092982A3 (fr) Procédé de détection et/ou d'identification de clostridium difficile
WO2010096594A3 (en) Method for identifying a subpopulation of mammalian cells with distinctive ribosome translation profiles
WO2005028621A3 (en) Assays with primary cells
WO2005031004A3 (de) Verfahren zum spezifischen schnellnachweis getränkeschädlicher mikroorganismen

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)